Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3a,Condition 3b
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,7,,CMO:0002943,renal filtration fraction,,,,0.233,,0.013,0.0344,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then vehicle control condition,99955,unilateral nephrectomy (for 28 days),vehicle control condition,,
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,8,,CMO:0002943,renal filtration fraction,,,,0.26,,0.013,0.0368,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition,99956,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,vehicle control condition,
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,8,,CMO:0002943,renal filtration fraction,,,,0.233,,0.12,0.3394,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days),99957,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,bosentan (100 mg/kg/d) (for 14 days),
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,8,,CMO:0002943,renal filtration fraction,,,,0.234,,0.14,0.396,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days),99958,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,enalapril (10 mg/kg/d) (for 14 days),
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,6,,CMO:0002943,renal filtration fraction,,,,0.21,,0.013,0.0318,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,28,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days),99959,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,enalapril (10 mg/kg/d) (for 14 days),bosentan (100 mg/kg/d) (for 14 days)
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,11,,CMO:0002943,renal filtration fraction,,,,0.23,,0.01,0.0332,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then vehicle control condition,99985,unilateral nephrectomy (for 28 days),vehicle control condition,,
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,17,,CMO:0002943,renal filtration fraction,,,,0.293,,0.011,0.0454,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition,99986,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,vehicle control condition,
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,17,,CMO:0002943,renal filtration fraction,,,,0.214,,0.011,0.0454,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days),99987,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,bosentan (100 mg/kg/d) (for 154 days),
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,16,,CMO:0002943,renal filtration fraction,,,,0.216,,0.01,0.04,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days),99988,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,enalapril (10 mg/kg/d) (for 154 days),
2378,"Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54.",glomerular filtration trait,,RS:0000742,WKY,male,0 days,16,,CMO:0002943,renal filtration fraction,,,,0.213,,0.007,0.028,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,unx,168,days,unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days),99989,unilateral nephrectomy (for 28 days),streptozotocin (35 mg/kg) ,enalapril (10 mg/kg/d) (for 154 days),bosentan (100 mg/kg/d) (for 154 days)
2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",glomerular filtration trait,,RS:0000580,MNS,male,126 days,6,,CMO:0002943,renal filtration fraction,((A-V)/A)*100,filtration fraction,,0.2463,,0.0208,0.0509,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,,,,control condition,104118,control condition,,,
2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",glomerular filtration trait,,RS:0000580,MNS,male,126 days,6,,CMO:0002943,renal filtration fraction,((A-V)/A)*100,filtration fraction,,0.3063,,0.0033,0.008,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,,,,streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days),104119,streptozotocin (55 mg/kg) ,insulin (4 IU/kg) (for 42 days),,
2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",glomerular filtration trait,,RS:0000577,MHS,male,126 days,6,,CMO:0002943,renal filtration fraction,((A-V)/A)*100,filtration fraction,,0.2418,,0.018,0.044,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,,,,control condition,104120,control condition,,,
2907,"Pugliese G, et al., Kidney Int. 2005 Apr;67(4):1440-52. doi: 10.1111/j.1523-1755.2005.00221.x.",glomerular filtration trait,,RS:0000577,MHS,male,126 days,6,,CMO:0002943,renal filtration fraction,((A-V)/A)*100,filtration fraction,,0.253,,0.0046,0.0112,MMO:0000634,inulin analysis by liquid phase colorimetry,,0.0,,,,,streptozotocin (55 mg/kg) then insulin (4 IU/kg) (for 42 days),104121,streptozotocin (55 mg/kg) ,insulin (4 IU/kg) (for 42 days),,